Mutations which affect the C-terminus of PDX1 are associated with the development of type 2 diabetes in humans [10–12], while other findings indicate that the C-terminal domain may serve as both repressor and activator of PDX1 function [13,14]. Here, PDX1 is linked to type 2 diabetes mellitus.